XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (334) $ (70)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 357 384
Deferred income taxes (129) 22
Stock-based compensation expense 12 16
Impairment and (gain) loss on sale of businesses, net 294 (9)
Gain from early extinguishment of debt (25)  
Other non-cash expenses, net 142 132
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:    
Patient accounts receivable 126 (119)
Supplies, prepaid expenses and other current assets (48) (100)
Accounts payable, accrued liabilities and income taxes (119) (69)
Other (12) (67)
Net cash provided by operating activities 264 120
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (1) (35)
Purchases of property and equipment (251) (357)
Proceeds from disposition of hospitals and other ancillary operations 174 123
Proceeds from sale of property and equipment 5 27
Purchases of available-for-sale debt securities and equity securities (54) (126)
Proceeds from sales of available-for-sale debt securities and equity securities 54 221
Purchases of investments in unconsolidated affiliates (4) (8)
Increase in other investments (55) (51)
Net cash used in investing activities (132) (206)
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (2) (4)
Deferred financing costs and other debt-related costs (8)  
Proceeds from noncontrolling investors in joint ventures 1 4
Redemption of noncontrolling investments in joint ventures (3) (1)
Distributions to noncontrolling investors in joint ventures (121) (108)
Other borrowings 18 30
Issuance of long-term debt 1,236  
Proceeds from ABL Facility 2,662 2,290
Repayments of long-term indebtedness (3,920) (2,152)
Net cash (used in) provided by financing activities (137) 59
Net change in cash and cash equivalents (5) (27)
Cash and cash equivalents at beginning of period 38 118
Cash and cash equivalents at end of period 33 91
Supplemental disclosure of cash flow information:    
Interest payments (562) (583)
Income tax payments, net $ (132) $ (61)